Jiang Shi

机构：Affiliated Hospital of Guizhou Medical University · ORCID：0000-0002-6332-4569

发表论文 34 篇 · 总被引 1043 次 · h-index 16

代表论文

• N6-methyladenosine-modified CircRNA-SORE sustains sorafenib resistance in hepatocellular carcinoma by regulating β-catenin signaling (2020 · Molecular Cancer · 被引 321)
• Baicalin alleviates chronic obstructive pulmonary disease through regulation of HSP72-mediated JNK pathway (2021 · Molecular Medicine · 被引 55)
• KLF5-induced BBOX1-AS1 contributes to cell malignant phenotypes in non-small cell lung cancer via sponging miR-27a-5p to up-regulate MELK and activate FAK signaling pathway (2021 · Journal of Experimental & Clinical Cancer Research · 被引 44)
• Circ_0006988 promotes the proliferation, metastasis and angiogenesis of non-small cell lung cancer cells by modulating miR-491-5p/MAP3K3 axis (2021 · Cell Cycle · 被引 24)
• CRISPR-Cas9-based genome-wide screening identified novel targets for treating sorafenib-resistant hepatocellular carcinoma: a cross-talk between FGF21 and the NRF2 pathway (2022 · Science China Life Sciences · 被引 22)
• Circulating miR-1246 Targeting UBE2C, TNNI3, TRAIP, UCHL1 Genes and Key Pathways as a Potential Biomarker for Lung Adenocarcinoma: Integrated Biological Network Analysis (2020 · Journal of Personalized Medicine · 被引 21)